Latest News

FDA Approves Finerenone for Heart Failure With LVEF ≥40% Following Positive Phase 3 Data
FDA Approves Finerenone for Heart Failure With LVEF ≥40% Following Positive Phase 3 Data

July 14th 2025

FDA approval based on FINEARTS-HF trial showing 16% risk reduction in CV death and HF events.

Weight Cycling Ups Risk for Heart Failure by 50%, Other Metabolic Diseases by Up to 30%: New Data
Weight Cycling Ups Risk for Heart Failure by 50%, Other Metabolic Diseases by Up to 30%: New Data

June 23rd 2025

Once-Weekly Insulin Efsitora Comparable to Daily Glargine for Hyperglycemia in Adults with Type 2 Diabetes / image credit ADA Julio Rosenstock, MD
Once-Weekly Insulin Efsitora Comparable to Daily Glargine for Hyperglycemia in Adults With Type 2 Diabetes

June 23rd 2025

Healthy Low-Carb or Low-Fat Diets Linked to Lower CVD Risk: Daily Dose / image credit: ©New Africa/AdobeStock
Healthy Low-Carb or Low-Fat Diets Linked to Lower CVD Risk: Daily Dose

June 19th 2025

Coexisting HTN, T2D in US Adults Doubled Over 2 Decades: Daily Dose / image credit: ©New Africa/AdobeStock
Coexisting HTN, T2D in US Adults Doubled Over 2 Decades: Daily Dose

June 18th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.